Back
Supernus Pharmaceuticals Stock Price Chart
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
31
SUPN
Supernus Pharmaceuticals
Last Price:
31.91
Seasonality Move:
-3.54%
7 Day Trial
ALL ACCESS PASS
$
7
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.06 | Buy |
| 20-day SMA: | 31.97 | Buy |
| 50-day SMA: | 32.23 | Sell |
| 200-day SMA: | 29.92 | Buy |
| 8-day EMA: | 31.28 | Buy |
| 20-day EMA: | 31.79 | Buy |
| 50-day EMA: | 31.67 | Buy |
| 200-day EMA: | 30.4 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 50.9 | Buy |
| Chaikin Money Flow: | 216149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.85 - 34.25) | Sell |
| Bollinger Bands (100): | (27.03 - 32.77) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 32.03 while SUPN 8-day simple moving average is 31.06, which is a Buy signal.
- The stock price of SUPN is 32.03 while Supernus Pharmaceuticals 20-day SMA is 31.97, which makes it a Buy.
- Supernus Pharmaceuticals 50-day simple moving average is 32.23 while SUPN share price is 32.03, making it a Sell technically.
- SUPN stock price is 32.03 and Supernus Pharmaceuticals 200-day simple moving average is 29.92, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
31
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $32.03. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.77B
Price in USD:
32.03
Share Volume:
353.91K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
35.44
52-Week Low:
21.99
Sell
31
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 32.03 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 32.03 while SUPN 8-day exponential moving average is 31.28, which is a Buy signal.
- The stock price of SUPN is 32.03 while Supernus Pharmaceuticals 20-day EMA is 31.79, which makes it a Buy.
- Supernus Pharmaceuticals 50-day exponential moving average is 31.67 while SUPN share price is 32.03, making it a Buy technically.
- SUPN stock price is 32.03 and Supernus Pharmaceuticals 200-day simple moving average is 30.40, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is -0.46, suggesting Supernus Pharmaceuticals is a Sell
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 50.9, which suggest Supernus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (30.85 - 34.25), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (27.03 - 32.77), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.